Uncontrolled, chronic inflammation is now considered a major component of many widespread diseases, which are now well-recognized as "inflammatory diseases." These include arthritis, asthma, atherosclerosis and peripheral vascular disease, Alzheimer’s disease, periodontal disease and cancer. There is general agreement that inflammation is not likely to be the causative factor in these diseases, but that it plays a key role in disease progression, tissue dysfunction, and ultimately organ failure. In recent years, evidence has emerged that resolution of inflammation is a biochemically active process driven by multiple chemical mediators. Elucidation of the biochemical pathways contributing to the resolution of inflammation has provided many new anti-inflammatory targets and an opportunity for resolution-based pharmacology for treatment and prevention of inflammatory diseases. This symposium reviews recent discoveries and advances in the field, and demonstrates how this work translates into new approaches and new pharmacology to treat old diseases.
Call for Poster and Presentation Abstracts:
Abstract submissions are invited for a poster session and brief oral presentations. For complete abstract instructions, send an e-mail to Inflammation@nyas.org with the words "Abstract Information" in the subject line. There is no need to type a message: instructions will be forwarded automatically. The deadline for abstract submission is September 26, 2014, and selected poster and oral presenters will be notified by October 3, 2014.